| 1 | characteristic | 4,089 |
| 2 | concentration-time | 913 |
| 3 | glow | 77 |
| 4 | time-concentration | 40 |
| 5 | time-activity | 37 |
| 6 | reagin | 32 |
| 7 | receiver-operating-characteristic | 20 |
| 8 | concentration-versus-time | 17 |
| 9 | predictiveness | 14 |
| 10 | time-intensity | 14 |
| 11 | volume-time | 14 |
| 12 | effect-time | 9 |
| 13 | 'learning | 8 |
| 14 | -time | 8 |
| 15 | tornado | 7 |
| 16 | force-distance | 6 |
| 17 | alkylresorcinol | 5 |
| 18 | concentration–time | 5 |
| 19 | kras-braf | 5 |
| 20 | adsorption/desorption | 4 |
| 21 | plateau-like | 4 |
| 22 | anvillea | 3 |
| 23 | concentration-vs.-time | 3 |
| 24 | concentration/time | 3 |
| 25 | g-v | 3 |
| 26 | j-v | 3 |
| 27 | level-time | 3 |
| 28 | nanotopographical | 3 |
| 29 | power-time | 3 |
| 30 | pressure-function | 3 |
| 31 | receiver-operator-characteristic | 3 |
| 32 | response-time | 3 |
| 33 | time-density | 3 |
| 34 | treacherous | 3 |
| 35 | vas-time | 3 |
| 36 | characteristic-derived | 2 |
| 37 | co-paw | 2 |
| 38 | concentration-contraction | 2 |
| 39 | cp-a | 2 |
| 40 | eadie-hofstee | 2 |
| 41 | eight-electrode | 2 |
| 42 | force-expansion | 2 |
| 43 | force-pca | 2 |
| 44 | gir-time | 2 |
| 45 | inhibition-time | 2 |
| 46 | kaplan-mayer | 2 |
| 47 | mass-spectrum | 2 |
| 48 | mooney-rivlin | 2 |
| 49 | n-alkylresorcinol | 2 |
| 50 | over-parameterized | 2 |
| 51 | pigmentovascularis | 2 |
| 52 | plasma-concentration-versus-time | 2 |
| 53 | pt-time | 2 |
| 54 | reheat | 2 |
| 55 | semi-log | 2 |
| 56 | sigmoid-emax | 2 |
| 57 | split-split | 2 |
| 58 | time-to-cancer | 2 |
| 59 | umklapp | 2 |
| 60 | 'roc | 1 |
| 61 | 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine | 1 |
| 62 | 22-day-old | 1 |
| 63 | 3,4,6-tri-o-galloyl-d-glucose | 1 |
| 64 | amount-time | 1 |
| 65 | analgesia-time | 1 |
| 66 | anticonvulsant/antiepileptic | 1 |
| 67 | area-time | 1 |
| 68 | area-under-the | 1 |
| 69 | area-under-the-concentration-time | 1 |
| 70 | area-under-the-rimonabant-concentration-by-time | 1 |
| 71 | arndt-schulz | 1 |
| 72 | bed-response | 1 |
| 73 | binding-dose-inhibition | 1 |
| 74 | biofingerprinting | 1 |
| 75 | bis-time | 1 |
| 76 | bufotenine | 1 |
| 77 | c/e-acceptability | 1 |
| 78 | characterictic | 1 |
| 79 | characteristic-curve | 1 |
| 80 | cmax-dose | 1 |
| 81 | cold-agglutinin | 1 |
| 82 | cp-prop-time | 1 |
| 83 | curve-determined | 1 |
| 84 | disability/time | 1 |
| 85 | dna-distribution | 1 |
| 86 | dose-responding | 1 |
| 87 | drug-concentration-over-time | 1 |
| 88 | efficacy-time | 1 |
| 89 | eid50virus | 1 |
| 90 | f-clearance | 1 |
| 91 | fac/blood-pressure | 1 |
| 92 | fluorescence-concentration | 1 |
| 93 | force-deflection | 1 |
| 94 | force-power | 1 |
| 95 | frequency-admittance | 1 |
| 96 | genocidal | 1 |
| 97 | glucose-time | 1 |
| 98 | guineafowl | 1 |
| 99 | healing-time | 1 |
| 100 | heat-absorption | 1 |
| 101 | heat-release | 1 |
| 102 | heat-time | 1 |
| 103 | honeyeater | 1 |
| 104 | hsp70.high | 1 |
| 105 | hyoseris | 1 |
| 106 | inr-time | 1 |
| 107 | interval-time | 1 |
| 108 | ladder-shaped | 1 |
| 109 | learnig | 1 |
| 110 | level/clinical | 1 |
| 111 | level/time | 1 |
| 112 | lisn | 1 |
| 113 | long-toed | 1 |
| 114 | medip-qpcr | 1 |
| 115 | minor-population | 1 |
| 116 | multi-step-type | 1 |
| 117 | noise-power-spectrum | 1 |
| 118 | norepinephrine-pressure | 1 |
| 119 | phase-solubility | 1 |
| 120 | plasma-time | 1 |
| 121 | polynomia | 1 |
| 122 | post-melting | 1 |
| 123 | power-speed | 1 |
| 124 | random-phased | 1 |
| 125 | rate-concentration | 1 |
| 126 | receiveroperator | 1 |
| 127 | recovery-phase | 1 |
| 128 | research.2009 | 1 |
| 129 | respectively.roc | 1 |
| 130 | room/case | 1 |
| 131 | scale-time | 1 |
| 132 | semilog | 1 |
| 133 | signal-time | 1 |
| 134 | spatial-plus-verbal | 1 |
| 135 | specific-activity | 1 |
| 136 | speed-distance | 1 |
| 137 | stretch-tension | 1 |
| 138 | sw-edv | 1 |
| 139 | temperature-susceptibility | 1 |
| 140 | the-concentration-time | 1 |
| 141 | therapy-predictive | 1 |
| 142 | through-focus | 1 |
| 143 | time-concentrations | 1 |
| 144 | time-sedation | 1 |
| 145 | time-strain | 1 |
| 146 | torque-time | 1 |
| 147 | tpy-cd | 1 |
| 148 | ubt-versus-time | 1 |
| 149 | yellow-spotted | 1 |
| 150 | μd-glycerol | 1 |
| 151 | •roc | 1 |
| 152 | ≥50-fold | 1 |
| 1 | 'learning | 8 |
| 2 | 'roc | 1 |
| 3 | -time | 8 |
| 4 | 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine | 1 |
| 5 | 22-day-old | 1 |
| 6 | 3,4,6-tri-o-galloyl-d-glucose | 1 |
| 7 | adsorption/desorption | 4 |
| 8 | alkylresorcinol | 5 |
| 9 | amount-time | 1 |
| 10 | analgesia-time | 1 |
| 11 | anticonvulsant/antiepileptic | 1 |
| 12 | anvillea | 3 |
| 13 | area-time | 1 |
| 14 | area-under-the | 1 |
| 15 | area-under-the-concentration-time | 1 |
| 16 | area-under-the-rimonabant-concentration-by-time | 1 |
| 17 | arndt-schulz | 1 |
| 18 | bed-response | 1 |
| 19 | binding-dose-inhibition | 1 |
| 20 | biofingerprinting | 1 |
| 21 | bis-time | 1 |
| 22 | bufotenine | 1 |
| 23 | c/e-acceptability | 1 |
| 24 | characterictic | 1 |
| 25 | characteristic | 4,089 |
| 26 | characteristic-curve | 1 |
| 27 | characteristic-derived | 2 |
| 28 | cmax-dose | 1 |
| 29 | co-paw | 2 |
| 30 | cold-agglutinin | 1 |
| 31 | concentration-contraction | 2 |
| 32 | concentration-time | 913 |
| 33 | concentration-versus-time | 17 |
| 34 | concentration-vs.-time | 3 |
| 35 | concentration/time | 3 |
| 36 | concentration–time | 5 |
| 37 | cp-a | 2 |
| 38 | cp-prop-time | 1 |
| 39 | curve-determined | 1 |
| 40 | disability/time | 1 |
| 41 | dna-distribution | 1 |
| 42 | dose-responding | 1 |
| 43 | drug-concentration-over-time | 1 |
| 44 | eadie-hofstee | 2 |
| 45 | effect-time | 9 |
| 46 | efficacy-time | 1 |
| 47 | eid50virus | 1 |
| 48 | eight-electrode | 2 |
| 49 | f-clearance | 1 |
| 50 | fac/blood-pressure | 1 |
| 51 | fluorescence-concentration | 1 |
| 52 | force-deflection | 1 |
| 53 | force-distance | 6 |
| 54 | force-expansion | 2 |
| 55 | force-pca | 2 |
| 56 | force-power | 1 |
| 57 | frequency-admittance | 1 |
| 58 | g-v | 3 |
| 59 | genocidal | 1 |
| 60 | gir-time | 2 |
| 61 | glow | 77 |
| 62 | glucose-time | 1 |
| 63 | guineafowl | 1 |
| 64 | healing-time | 1 |
| 65 | heat-absorption | 1 |
| 66 | heat-release | 1 |
| 67 | heat-time | 1 |
| 68 | honeyeater | 1 |
| 69 | hsp70.high | 1 |
| 70 | hyoseris | 1 |
| 71 | inhibition-time | 2 |
| 72 | inr-time | 1 |
| 73 | interval-time | 1 |
| 74 | j-v | 3 |
| 75 | kaplan-mayer | 2 |
| 76 | kras-braf | 5 |
| 77 | ladder-shaped | 1 |
| 78 | learnig | 1 |
| 79 | level-time | 3 |
| 80 | level/clinical | 1 |
| 81 | level/time | 1 |
| 82 | lisn | 1 |
| 83 | long-toed | 1 |
| 84 | mass-spectrum | 2 |
| 85 | medip-qpcr | 1 |
| 86 | minor-population | 1 |
| 87 | mooney-rivlin | 2 |
| 88 | multi-step-type | 1 |
| 89 | n-alkylresorcinol | 2 |
| 90 | nanotopographical | 3 |
| 91 | noise-power-spectrum | 1 |
| 92 | norepinephrine-pressure | 1 |
| 93 | over-parameterized | 2 |
| 94 | phase-solubility | 1 |
| 95 | pigmentovascularis | 2 |
| 96 | plasma-concentration-versus-time | 2 |
| 97 | plasma-time | 1 |
| 98 | plateau-like | 4 |
| 99 | polynomia | 1 |
| 100 | post-melting | 1 |
| 101 | power-speed | 1 |
| 102 | power-time | 3 |
| 103 | predictiveness | 14 |
| 104 | pressure-function | 3 |
| 105 | pt-time | 2 |
| 106 | random-phased | 1 |
| 107 | rate-concentration | 1 |
| 108 | reagin | 32 |
| 109 | receiver-operating-characteristic | 20 |
| 110 | receiver-operator-characteristic | 3 |
| 111 | receiveroperator | 1 |
| 112 | recovery-phase | 1 |
| 113 | reheat | 2 |
| 114 | research.2009 | 1 |
| 115 | respectively.roc | 1 |
| 116 | response-time | 3 |
| 117 | room/case | 1 |
| 118 | scale-time | 1 |
| 119 | semi-log | 2 |
| 120 | semilog | 1 |
| 121 | sigmoid-emax | 2 |
| 122 | signal-time | 1 |
| 123 | spatial-plus-verbal | 1 |
| 124 | specific-activity | 1 |
| 125 | speed-distance | 1 |
| 126 | split-split | 2 |
| 127 | stretch-tension | 1 |
| 128 | sw-edv | 1 |
| 129 | temperature-susceptibility | 1 |
| 130 | the-concentration-time | 1 |
| 131 | therapy-predictive | 1 |
| 132 | through-focus | 1 |
| 133 | time-activity | 37 |
| 134 | time-concentration | 40 |
| 135 | time-concentrations | 1 |
| 136 | time-density | 3 |
| 137 | time-intensity | 14 |
| 138 | time-sedation | 1 |
| 139 | time-strain | 1 |
| 140 | time-to-cancer | 2 |
| 141 | tornado | 7 |
| 142 | torque-time | 1 |
| 143 | tpy-cd | 1 |
| 144 | treacherous | 3 |
| 145 | ubt-versus-time | 1 |
| 146 | umklapp | 2 |
| 147 | vas-time | 3 |
| 148 | volume-time | 14 |
| 149 | yellow-spotted | 1 |
| 150 | μd-glycerol | 1 |
| 151 | •roc | 1 |
| 152 | ≥50-fold | 1 |
| 1 | research.2009 | 1 |
| 2 | cp-a | 2 |
| 3 | force-pca | 2 |
| 4 | anvillea | 3 |
| 5 | polynomia | 1 |
| 6 | characterictic | 1 |
| 7 | anticonvulsant/antiepileptic | 1 |
| 8 | characteristic | 4,089 |
| 9 | receiver-operating-characteristic | 20 |
| 10 | receiver-operator-characteristic | 3 |
| 11 | 'roc | 1 |
| 12 | respectively.roc | 1 |
| 13 | •roc | 1 |
| 14 | tpy-cd | 1 |
| 15 | power-speed | 1 |
| 16 | curve-determined | 1 |
| 17 | long-toed | 1 |
| 18 | ladder-shaped | 1 |
| 19 | random-phased | 1 |
| 20 | yellow-spotted | 1 |
| 21 | characteristic-derived | 2 |
| 22 | over-parameterized | 2 |
| 23 | 22-day-old | 1 |
| 24 | ≥50-fold | 1 |
| 25 | f-clearance | 1 |
| 26 | speed-distance | 1 |
| 27 | force-distance | 6 |
| 28 | frequency-admittance | 1 |
| 29 | eight-electrode | 2 |
| 30 | eadie-hofstee | 2 |
| 31 | area-under-the | 1 |
| 32 | plateau-like | 4 |
| 33 | -time | 8 |
| 34 | concentration-vs.-time | 3 |
| 35 | area-time | 1 |
| 36 | analgesia-time | 1 |
| 37 | plasma-time | 1 |
| 38 | scale-time | 1 |
| 39 | volume-time | 14 |
| 40 | response-time | 3 |
| 41 | glucose-time | 1 |
| 42 | torque-time | 1 |
| 43 | healing-time | 1 |
| 44 | signal-time | 1 |
| 45 | interval-time | 1 |
| 46 | level-time | 3 |
| 47 | concentration-time | 913 |
| 48 | the-concentration-time | 1 |
| 49 | area-under-the-concentration-time | 1 |
| 50 | inhibition-time | 2 |
| 51 | cp-prop-time | 1 |
| 52 | drug-concentration-over-time | 1 |
| 53 | power-time | 3 |
| 54 | gir-time | 2 |
| 55 | inr-time | 1 |
| 56 | vas-time | 3 |
| 57 | bis-time | 1 |
| 58 | concentration-versus-time | 17 |
| 59 | plasma-concentration-versus-time | 2 |
| 60 | ubt-versus-time | 1 |
| 61 | heat-time | 1 |
| 62 | effect-time | 9 |
| 63 | amount-time | 1 |
| 64 | pt-time | 2 |
| 65 | area-under-the-rimonabant-concentration-by-time | 1 |
| 66 | efficacy-time | 1 |
| 67 | level/time | 1 |
| 68 | concentration/time | 3 |
| 69 | disability/time | 1 |
| 70 | concentration–time | 5 |
| 71 | 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine | 1 |
| 72 | bufotenine | 1 |
| 73 | multi-step-type | 1 |
| 74 | fac/blood-pressure | 1 |
| 75 | norepinephrine-pressure | 1 |
| 76 | room/case | 1 |
| 77 | heat-release | 1 |
| 78 | recovery-phase | 1 |
| 79 | bed-response | 1 |
| 80 | 3,4,6-tri-o-galloyl-d-glucose | 1 |
| 81 | cmax-dose | 1 |
| 82 | therapy-predictive | 1 |
| 83 | characteristic-curve | 1 |
| 84 | kras-braf | 5 |
| 85 | learnig | 1 |
| 86 | dose-responding | 1 |
| 87 | 'learning | 8 |
| 88 | post-melting | 1 |
| 89 | biofingerprinting | 1 |
| 90 | semi-log | 2 |
| 91 | semilog | 1 |
| 92 | hsp70.high | 1 |
| 93 | spatial-plus-verbal | 1 |
| 94 | nanotopographical | 3 |
| 95 | level/clinical | 1 |
| 96 | genocidal | 1 |
| 97 | alkylresorcinol | 5 |
| 98 | n-alkylresorcinol | 2 |
| 99 | μd-glycerol | 1 |
| 100 | guineafowl | 1 |
| 101 | noise-power-spectrum | 1 |
| 102 | mass-spectrum | 2 |
| 103 | time-strain | 1 |
| 104 | reagin | 32 |
| 105 | mooney-rivlin | 2 |
| 106 | cold-agglutinin | 1 |
| 107 | force-expansion | 2 |
| 108 | stretch-tension | 1 |
| 109 | time-sedation | 1 |
| 110 | minor-population | 1 |
| 111 | fluorescence-concentration | 1 |
| 112 | time-concentration | 40 |
| 113 | rate-concentration | 1 |
| 114 | concentration-contraction | 2 |
| 115 | force-deflection | 1 |
| 116 | pressure-function | 3 |
| 117 | binding-dose-inhibition | 1 |
| 118 | heat-absorption | 1 |
| 119 | adsorption/desorption | 4 |
| 120 | dna-distribution | 1 |
| 121 | lisn | 1 |
| 122 | tornado | 7 |
| 123 | umklapp | 2 |
| 124 | medip-qpcr | 1 |
| 125 | time-to-cancer | 2 |
| 126 | honeyeater | 1 |
| 127 | force-power | 1 |
| 128 | kaplan-mayer | 2 |
| 129 | receiveroperator | 1 |
| 130 | pigmentovascularis | 2 |
| 131 | hyoseris | 1 |
| 132 | time-concentrations | 1 |
| 133 | predictiveness | 14 |
| 134 | through-focus | 1 |
| 135 | treacherous | 3 |
| 136 | eid50virus | 1 |
| 137 | reheat | 2 |
| 138 | split-split | 2 |
| 139 | g-v | 3 |
| 140 | j-v | 3 |
| 141 | sw-edv | 1 |
| 142 | co-paw | 2 |
| 143 | glow | 77 |
| 144 | sigmoid-emax | 2 |
| 145 | c/e-acceptability | 1 |
| 146 | temperature-susceptibility | 1 |
| 147 | phase-solubility | 1 |
| 148 | time-density | 3 |
| 149 | time-intensity | 14 |
| 150 | specific-activity | 1 |
| 151 | time-activity | 37 |
| 152 | arndt-schulz | 1 |